President Barack Obama met with Mexico's President Felipe Calderon and Canadian Prime Minister Stephen Harper in Guadalajara Monday to discuss H1N1 flu prevention and efforts to combat a deadly cross-border drug trade.
OCHRAB, Cambodia | In this reporter's notebook, NewsHour correspondent Fred de Sam Lazaro writes about tracking the growing resistance to the malaria drug artemisinin in western Cambodia.
TASANH, Cambodia | A stream of poor-quality and counterfeit malaria drugs coming into Cambodia is contributing to growing resistance to treatment for the disease near the Thai-Cambodian border.
The Supreme Court ruled 8-1 Thursday that officials at an Arizona school went too far when they strip searched an eighth-grader accused of distributing drugs. Marcia Coyle of The National Law Journal discusses the ruling with Jim Lehrer.
By PBS NewsHour
The world's largest drug maker, Pfizer Inc., announced Monday it is acquiring rival company Wyeth for about $68 billion, in the largest pharmaceutical sector takeover since 2000.
Dr. Charles Shepard spoke to NewsHour health correspondent Susan Dentzer about the benefits and bumps along the road in using electronic health records.
Rick Koca created a nonprofit organization designed to help homeless children across the country. He is nominated for the Purpose Prize, which honors retirees who initiate social programs.
NewsHour essayist Anne Taylor Fleming shares some thoughts about rehabilitation following addiction and its effects on families.
A new study has found that the use of drugs and stents, which are tiny metal scaffolds placed in clogged arteries, may be no better than using drugs alone in non-emergency situations. Two cardiologists discuss the findings.
President Bush visited Mexico on Tuesday, the last stop on his five-country tour of Latin America, and vowed to push Congress to change U.S. immigration policies. Two regional experts discuss the president's visit and the future of Mexican trade and…
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.